These results suggested that the P2X7 receptor can mediate the NLRP3/caspase-1-induced pyroptosis to regulate hyperglycemia changes and further supported that the P2X7 receptor can be a potential target for the treatment of diabetic cardiomyopathy. The gene discussed is CASP1; the disease is diabetic cardiomyopathy.